Business Daily from THE HINDU group of publications
Tuesday, Nov 07, 2006
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - IPR
NBRI tech transfer to Alchemist

Our Bureau

New Delhi, Nov. 4

The National Botanical Research Institute of India has recently transferred four patented technologies to Alchemist Ltd. The Rs 1,500-crore company is likely to start production of the four nutraceutical products in November. They include Nutra-lact, Nutra-balyog, Nutra-preg which would address the problem of malnutrition and the anti-diabetic drug Nutra-diab.

"The future is in affordable healthcare, and we will be moving in these identified areas very aggressively and aim to be a significant group in healthcare very soon. We will take these home-grown and researched products and turn them into potent OTC brands very quickly," said Mr K.D. Singh, Chairman, Alchemist Group.

More Stories on : IPR | Healthcare Products | Science & Technology

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Meet on corporate placements


Dunlop stops production in Chennai
Bajaj awards
NBRI tech transfer to Alchemist
Tata Steel will continue to look for acquisitions
Govt role sought in FACT merger
`Cos must not be led by market expectations'
Nahar Industrial earmarks Rs 800 cr for expansion
Suzlon Energy unveils major expansion
ONGC, Hinduja may sign pact
Volvo Bus to set up new jt venture in India
HAL unit signs pact with Cenco
`Business cannot ignore social, eco aspects'
Shri Lakshmi Cotysn o focus on cotton
Koncept Ambience takes up Rs 300-cr housing project
Bombardier bullish on Indian market
NatSteel to expand capacity


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line